Search

everythinglearnresearchcommunity

for

Search:↓

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Finasteride treatment changes urine metabolomics and steroid signatures, potentially monitoring effectiveness but may cause sexual side effects.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Elastic Net DNA methylation clocks are inaccurate for predicting age and health status; a "noise barometer" may better indicate aging and disease.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

ZDHHC17 methylation may help treat or identify facial skin aging.

Hair cortisol levels in brown bears can be affected by both long-term and short-term stress.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Mechanical stimulation and new therapies show promise for hair regrowth.

The LTF gene may help predict and manage nonspecific orbital inflammation.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

High levels of HSP70 and IL-15 are linked to more severe alopecia areata.

Aging dermal papilla cells can be reprogrammed for potential hair growth and skin repair.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

SCD1 inhibitors can cause skin issues in rodents.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

New genetic discoveries may lead to better treatments for alopecia areata.

Personalized skincare can be improved by understanding genetic differences and using compounds like Resveratrol and Quercetin.

Dysplastic nevi have unique gene expressions, making them distinct from common melanocytic nevi.

AIRE deficiency causes hair loss similar to alopecia areata in mice.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Stem cell treatment from umbilical cords reduces symptoms of atopic dermatitis and may help hair growth.